Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 26, 1994 - Issue 3
Submit an article Journal homepage
4
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Serum Hepatitis C Virus RNA Levels in Chronic Hepatitis C-Importance for outcome of interferon alfa-2b treatment

Zhi Bing Yun Departments of Virology, Central Microbiological Laboratory of the Stockholm County Council, Stockholm
,
Olle Reichard Infectious Diseases, Karolinska Institute, Danderyds Hospital, Danderyd
,
Margaret Chen Departments of Virology, Central Microbiological Laboratory of the Stockholm County Council, Stockholm
,
Joakim Lundeberg Biochemistry and Biotechnology, Royal Institute of Technology, Stockholm
,
Gunnar Norkrans Infectious Diseases, East Hospital, University of Gothenburg, Gothenburg
,
Aril Fryden Infectious Diseases, University Hospital of Linköping, Linköping
,
Anders Sönnerborg Departments of Virology, Central Microbiological Laboratory of the Stockholm County Council, Stockholm; Immunology, Microbiology, Pathology and Infectious Diseases, Division of Infectious Diseases, Karolinska Institute, Huddinge Hospital, Huddinge, Sweden
&
Ola Weiland Immunology, Microbiology, Pathology and Infectious Diseases, Division of Infectious Diseases, Karolinska Institute, Huddinge Hospital, Huddinge, Sweden
 show all
Pages 263-270 | Received 31 Jan 1994, Accepted 21 Mar 1994, Published online: 08 Jul 2009

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

M. Damen, C. J. Weegink, E. P. Mauser-Bunschoten, H. T. M. Cuypers, M.-C. Hermus, P. Sillekens, E. Haan, H. M. van den Berg, D. Bresters, P. N. Lelie, R. A. F. M. Chamuleau, H. W. Reesink. (2001) Sustained Virological Response in Chronic Hepatitis C Patients after a 6- and a 36-Month Interferon-a2b Treatment Schedule. A Multicenter, Randomized, Controlled Study. Scandinavian Journal of Gastroenterology 36:1, pages 97-104.
Read now
D. Grandér, R. Hultcrantz, O. Weiland, B. Xu, O. Sangfelt, A.-C. Björklund, R. Befrits, M. Björkholm, A. Gruber, N. Kinnman, O. Reichard, A. Widell & S. Einhorn. (1996) Factors Influencing the Response to Interferon Therapy in Chronic Hepatitis C Studies on Viral Genotype and Induction of 2′,5′-Oligoadenylate Synthetase in the Liver and Peripheral Blood Cells. Scandinavian Journal of Gastroenterology 31:6, pages 604-611.
Read now
Ola Weiland, Margaret Chen, Gudrun Lindh, Lars Mattsson, Robert Schvarcz, Anders Sönnerborg, Martin Wahl, Rune Wejstål, Anders Widell & Gunnar Norkrans. (1995) Efficacy of Human Leucocyte Alpha-Interferon Treatment for Chronic Hepatitis C Virus Infection. Scandinavian Journal of Infectious Diseases 27:4, pages 319-324.
Read now

Articles from other publishers (21)

Josephat Makokha. (2018) Invasion of <i>Cestrum aurantiacum</i> Lindl. in Kenya. Journal of Environmental Protection 09:06, pages 671-690.
Crossref
Yupeng He & Michael G. Katze. (2002) To Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon. Viral Immunology 15:1, pages 95-119.
Crossref
Sara KukuczkaLeonard E. Grosso. (2002) Effective Management of Hepatitis C Molecular Testing Improves Test Use Without Compromising Patient Management. Archives of Pathology & Laboratory Medicine 126:1, pages 100-102.
Crossref
Ezequiel Balmori Melian & Greg L. Plosker. (2001) Interferon Alfacon-1. Drugs 61:11, pages 1661-1691.
Crossref
Donald M Jensen, Edward L Krawitt, Emmet B Keeffe, Blaine F Hollinger, Stephen P James, Kevin Mullen, Gregory T Everson, John C Hoefs, Hans Fromm, Martin Black, Robert T Foust, Neville R Pimstone, Jenny E L Heathcote & Donald Albert. (1999) Biochemical and Viral Response to Consensus Interferon (Cifn) Therapy in Chronic Hepatitis C Patients: Effect of Baseline Viral Concentration. American Journal of Gastroenterology 94:12, pages 3583-3588.
Crossref
Chihiro Morishima & David R. Gretch. (1999) CLINICAL USE OF HEPATITIS C VIRUS TESTS FOR DIAGNOSIS AND MONITORING DURING THERAPY. Clinics in Liver Disease 3:4, pages 717-740.
Crossref
Andreas Ambrosch & Wolfgang König. (1999) Charakteristika des Hepatitis-C-Virus und virale Prädiktoren der therapeutischen InterventionCharacteristics of hepatitis C-Virus and viral predictors of therapeutical response. Medizinische Klinik 94:11, pages 626-632.
Crossref
Stephen J. Polyak, Denise M. Paschal, Susan McArdle, Michael J. Jr.Darius Moradpour & David R. Gretch. (1999) Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology 29:4, pages 1262-1271.
Crossref
Richard L. Hodinka. 1999. Viral Hepatitis. Viral Hepatitis 193 249 .
Stephen J. Polyak, Susan McArdle, Shan-Lu Liu, Daniel G. Sullivan, Minjun Chung, Wolfgang T. Hofgärtner, Robert L. CarithersJr.Jr., Brian J. McMahon, James I. Mullins, Lawrence Corey & David R. Gretch. (1998) Evolution of Hepatitis C Virus Quasispecies in Hypervariable Region 1 and the Putative Interferon Sensitivity-Determining Region during Interferon Therapy and Natural Infection. Journal of Virology 72:5, pages 4288-4296.
Crossref
Richard L Hodinka. (1998) The clinical utility of viral quantitation using molecular methods. Clinical and Diagnostic Virology 10:1, pages 25-47.
Crossref
Olle Reichard, Gunnar Norkrans, Aril Frydén, Jean-Henrik Braconier, Anders Sönnerborg & Ola Weiland. (1998) Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. The Lancet 351:9096, pages 83-87.
Crossref
A. H. Isaacson, G. L. Davis & J. Y. N. Lau. (2003) Should we test hepatitis C virus genotype and viraemia level in patients with chronic hepatitis C?. Journal of Viral Hepatitis 4:5, pages 285-292.
Crossref
Norah A. Terrault. (1996) Treatment of Chronic Hepatitis B and Chronic Hepatitis C. Reviews in Medical Virology 6:4, pages 215-228.
Crossref
Silvio Magrin, Antonio Craxi, Carmelo Fabiano, Liliana Marino, Germana Fiorentino, Oreste Lo Iacono, Riccardo Volpes, Vito Di Marco, Piero Almasio, Alessandra Vaccaro, Mickey S. Urdea, Judith C. Wilber, Celestino Bonoura, Fabrizio Gianguzza, Vincenza Capursi, Salvatore Filiberti, Lieven Stuyver & Luigi Pagliaro. (1996) HCV viraemia is more important than genotype as a predictor of response to interferon in sicily (Southern Italy). Journal of Hepatology 25:5, pages 583-590.
Crossref
F. García, C. Roldàn, J. Hernàndez-Quero, M. C. Bernal, M. A. Martínez, M. A. López, G. Piédrola & M. C. Maroto. (1996) Relationship between viral genotype and viral load in patients with chronic hepatitis C. European Journal of Clinical Microbiology & Infectious Diseases 15:11, pages 884-887.
Crossref
Maureen M. Jonas. (1996) Interferon-α for Viral Hepatitis. Journal of Pediatric Gastroenterology &amp Nutrition 23:2, pages 93-106.
Crossref
Maureen M. Jonas. (1996) Hepatitis C virus infection: clinical aspects and treatment with interferon alfa. Clinical Therapeutics 18, pages 110-125.
Crossref
David R. Gretch, Stephen J. Polyak, Richard A. Willson & Robert L. CarithersJr.Jr.. 1996. Antiviral Chemotherapy 4. Antiviral Chemotherapy 4 207 224 .
S. Shev, G. Norkrans, Annika Lindholm, A. Widell, Siv Månsson, Ulla Foberg, A. Frydén, S. Hermodsson, Gudrun Lindh & O. Weiland. (1995) HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profileHCV-Genotypen bei schweidischen Blutspendern und Beziehung zu Epidemiologie, Lebererkrankung und Hepatitis-C-Virus-Antikörperprofil. Infection 23:5, pages 253-257.
Crossref
Olle Reichard, Hans Glaumann, Aril Frydén, Gunnar Norkrans, Robert Schvarcz, Anders Sönnerborg, Zhi-Bing Yun & Ola Weiland. (1995) Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology 21:4, pages 918-922.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.